Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 13.5212.669.7511.266.24

What is the latest Core EBITDA Margin ratio of ORCHID PHARMA ?

The latest Core EBITDA Margin ratio of ORCHID PHARMA is 13.52 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202413.52
Mar202312.66
Mar20229.75
Mar202111.26
Mar20206.24

How is Core EBITDA Margin of ORCHID PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2024 13.52
6.79
Mar2023 12.66
29.85
Mar2022 9.75
-13.41
Mar2021 11.26
80.45
Mar2020 6.24 -

Other Financial Ratios of ORCHID PHARMA


Compare Core EBITDA Margin ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹7,828.8 Cr -3.7% -13.8% 124.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,715.0 Cr 0.3% -2.6% 36.7% Stock Analytics
DIVIS LABORATORIES ₹154,460.0 Cr -1% -0.5% 60.8% Stock Analytics
CIPLA ₹115,271.0 Cr -1.4% -3.1% 11.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,511.0 Cr -3.8% -4% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,189.5 Cr 0.1% 1.2% 40.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-3.7%

-13.8%

124.7%

SENSEX

-0.9%

-4.3%

3.7%


You may also like the below Video Courses